Copertina

Intracranial Hemorrhage Following Oral Low-Dose Methotrexate After Multiple Toxicities Caused by High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia

An 11-year-old male patient with the deletion of IKZF1 (Ikaros family zinc finger 1) and positive Breakpoint Cluster Region-C-Abelson oncogene 1(BCR-ABL1) acute lymphoblastic leukemia developed mucositis, gastrointestinal toxicity, hepatotoxicity, myelosuppression, and severe dermatologic toxicity d...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Ning Xin (Autore), Zhou Fen (Autore), Cheng Li (Autore), Xiao Yan (Autore), Jin Runming (Autore)
Natura:	Libro
Pubblicazione:	Frontiers Media S.A., 2019-09-01T00:00:00Z.
Soggetti:	article
Accesso online:	Connect to this object online.
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

High-Dose Methotrexate-Induced Idiopathic Intracranial Hypertension in Infant Acute Lymphoblastic Leukemia
di: Yazhi Zhang, et al.
Pubblicazione: (2020)

Retrospective evaluation and prediction of clearance and toxicity of high dose methotrexate in childhood acute lymphoblastic leukemia patients
di: Yuxia Shan, et al.
Pubblicazione: (2021)

Association between high-dose methotrexate-induced toxicity and polymorphisms within methotrexate pathway genes in acute lymphoblastic leukemia
di: Meng Xu, et al.
Pubblicazione: (2022)

High dose methotrexate in the treatment of children with acute lymphoblastic leukemia
di: Johannes Bondan Lukito
Pubblicazione: (2007)

Effect of methotrexate and doxorubicin cumulative doses on superoxide dismutase levels in childhood acute lymphoblastic leukemia
di: Khalida Fetriyani Ningsih, et al.
Pubblicazione: (2015)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
di: Xuan Gao, et al.
Pubblicazione: (2021)

Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia
di: Min Zhan, et al.
Pubblicazione: (2023)

Differential metabolomic pathway analysis in Malaysian childhood acute lymphoblastic leukemia patients treated with high-dose methotrexate
di: Rizal Husaini Razali, et al.
Pubblicazione: (2024)

MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy
di: Umerez M, et al.
Pubblicazione: (2017)

The influence of detoxification agents on the intensity of side effects caused by medium-high doses of methotrexate in children with acute lymphoblastic leukemia: Case series
di: Šumar Jovana S., et al.
Pubblicazione: (2014)

Development and Validation of UHPLC-MS/MS Assay for Therapeutic Drug Monitoring of High-dose Methotrexate in Children with Acute Lymphoblastic Leukemia
di: Lian LJ, et al.
Pubblicazione: (2020)

Effect of SLCO1B1 Polymorphisms on High‐Dose Methotrexate Clearance in Children and Young Adults With Leukemia and Lymphoblastic Lymphoma
di: Rachael R. Schulte, et al.
Pubblicazione: (2021)

A Risk Scoring Model for High-Dose Methotrexate-Induced Liver Injury in Children With Acute Lymphoblastic Leukemia Based on Gene Polymorphism Study
di: Xia He, et al.
Pubblicazione: (2021)

The effects of Astragalus polysaccharides, tragacanthin, and bassorin on methotrexate-resistant acute lymphoblastic leukemia
di: Bahareh Samii, et al.
Pubblicazione: (2023)

Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells
di: Yao Chen, et al.
Pubblicazione: (2024)

Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay
di: Julia E. Möhlmann, et al.
Pubblicazione: (2024)

Adverse Oral Reactions Associated with Low Doses of Methotrexate
di: N. V. Izmozherova, et al.
Pubblicazione: (2020)

Pancytopenia and stomatitis induced by low-dose methotrexate use
di: Hüseyin Yildiz, et al.
Pubblicazione: (2017)

Novel genomic variants influencing methotrexate delayed clearance in pediatric patients with acute lymphoblastic leukemia
di: Jung Yoon Choi, et al.
Pubblicazione: (2024)

Clinical pharmacokinetics of methotrexate in the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma in pediatric patients
di: Škorić Biljana, et al.
Pubblicazione: (2020)

Total cumulative dose of methotrexate is not the same as continuous cumulative dose: A clinician's perspective
di: Binod K Khaitan, et al.
Pubblicazione: (2020)

Failure Rate of Single Dose Methotrexate in Managment of Ectopic Pregnancy
di: Feras Sendy, et al.
Pubblicazione: (2015)

Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate
di: Magdalena Cwiklinska, et al.
Pubblicazione: (2020)

Renal function as a predicting model for plasma methotrexate concentration after high-dose methotrexate chemotherapy in pediatric malignancy
di: Kaveh Jaseb, et al.
Pubblicazione: (2018)

Effect of maintenance therapy for childhood with acute lymphoblastic leukaemia by combination of methotrexate and 6-mercaptopurine on the liver.
di: Abid T. Firas, et al.
Pubblicazione: (2005)

External Evaluation of Population Pharmacokinetic Models of Methotrexate for Model-Informed Precision Dosing in Pediatric Patients with Acute Lymphoid Leukemia
di: Shengfeng Wang, et al.
Pubblicazione: (2023)

Cutaneous manifestations of systemic methotrexate toxicity
di: Shivani Jain, MPhil, MSc, et al.
Pubblicazione: (2024)

Oral events related to low-dose methotrexate in rheumatoid arthritis patients
di: Carlos Henrique Silva Pedrazas, et al.
Pubblicazione: (2010)

Successful treatment of hydroxyurea-associated panniculitis and vasculitis with low-dose methotrexate
di: Sarah Mattessich, BS, et al.
Pubblicazione: (2017)

Newer Insights Into The Mechanism Of Action Of Low Dose Weekly Methotrexate In Psoriasis
di: Babu Raja K K, et al.
Pubblicazione: (2000)

Scabies‐induced perforating dermatosis successfully treated with low dose methotrexate
di: Elena Ippoliti, et al.
Pubblicazione: (2024)

The Role of Genetic Polymorphisms in High-Dose Methotrexate Toxicity and Response in Hematological Malignancies: A Systematic Review and Meta-Analysis
di: Zaiwei Song, et al.
Pubblicazione: (2021)

Improving measured health-related quality of life with outpatient high-dose methotrexate regimen among oncology patients with intracranial metastases: A systematic assessment
di: Heun Min, et al.
Pubblicazione: (2023)

Benefits of Low-Dose CT Scan of Head for Patients With Intracranial Hemorrhage
di: Dan Wu, et al.
Pubblicazione: (2020)

Glutamine mouthwash for preventing methotrexate-induced mucositis in children with acute lymphoblastic leukemia: A randomized cross-over trial
di: Siva Sankaran, et al.
Pubblicazione: (2024)

Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis
di: Marinella Patanè, et al.
Pubblicazione: (2013)

Outcomes of infant medulloblastoma treated without intraventricular methotrexate/high-dose chemotherapy
di: Gnanamani Senguttuvan, et al.
Pubblicazione: (2024)

Idiosyncratic reaction to single 7.5 mg dose of methotrexate: Mishappening by chance
di: Pallavi Kumari, et al.
Pubblicazione: (2021)

GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
di: Israel Ríos, et al.
Pubblicazione: (2022)

Monomorphic bullous hemorrhagic varicella in a patient on methotrexate
di: Swastika Suvirya, et al.
Pubblicazione: (2018)